Cargando…
Potential anti‐SARS‐CoV‐2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease
A novel coronavirus [severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), or 2019 novel coronavirus] has been identified as the pathogen of coronavirus disease 2019. The main protease (M(pro), also called 3‐chymotrypsin‐like protease) of SARS‐CoV‐2 is a potential target for treatment of COV...
Autor principal: | Tsuji, Motonori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262888/ https://www.ncbi.nlm.nih.gov/pubmed/32374074 http://dx.doi.org/10.1002/2211-5463.12875 |
Ejemplares similares
-
The ChEMBL database in 2017
por: Gaulton, Anna, et al.
Publicado: (2017) -
ChEMBL-Likeness Score and Database GDBChEMBL
por: Bühlmann, Sven, et al.
Publicado: (2020) -
The ChEMBL bioactivity database: an update
por: Bento, A. Patrícia, et al.
Publicado: (2014) -
The ChEMBL database as linked open data
por: Willighagen, Egon L, et al.
Publicado: (2013) -
ChEMBL: a large-scale bioactivity database for drug discovery
por: Gaulton, Anna, et al.
Publicado: (2012)